Furthermore, it is widely known that NSAIDs with stronger COX-1 inhibition are more likely to induce asthma attacks; thus, the main feature of N-ERD is now considered to be COX-1 inhibitor intolerance (1–3, 5). Here, PTGS1 is linked to asthma.